Fukano Kentaro, Iizuka Yusuke, Ueda Takahiro, Fukuda Yu, Otsuka Yuji, Sanui Masamitsu
Department of Anesthesiology and Critical Care, Jichi Medical University Saitama Medical Center, Saitama, JPN.
Cureus. 2023 Jul 29;15(7):e42650. doi: 10.7759/cureus.42650. eCollection 2023 Jul.
Procedural sedation is increasingly used for elderly patients, but there is no established ideal method for elderly patients who are prone to respiratory and circulatory depression. This study aims to investigate the association of respiratory complications and the combination of ketamine-propofol versus fentanyl-propofol in elderly patients undergoing prostate biopsy requiring deep sedation.
This was a single-center, retrospective, observational study conducted from April 2020 to March 2021. We included male patients aged 65 years and older scheduled for prostate biopsy under procedural sedation. Ketamine-propofol and fentanyl-propofol were administered at the discretion of the anesthesiologist. The primary outcome was the need for assisted ventilation. The secondary outcome was the duration of oxygen saturation (SpO) below 90%.
We enrolled 120 patients over 65 years, and 92 patients were included in the final analysis. The anesthesiologist administered an initial dose of ketamine and propofol of 1:1 to 1:4 of 1.0 mg kg (interquartile range: 0.98 to 1.17) or administered an initial dose of fentanyl of 0.05 to 0.1 mg and a target-controlled infusion of propofol of 2.8 μg ml (interquartile range: 2.0 to 3.0) followed by additional doses at the discretion of the anesthesiologist. Ketamine-propofol was associated with a reduced need for assisted ventilation and a shorter duration of SpO2 below 90% than propofol-fentanyl (95.7% vs. 4.3%, P < 0.05; 0.64 minutes vs. 0.17 minutes, P = 0.26).
Ketamine-propofol is associated with a significantly reduced need for assisted ventilation compared to propofol-fentanyl during procedural sedation and analgesia for procedures requiring deep sedation for the elderly.
程序性镇静越来越多地用于老年患者,但对于易发生呼吸和循环抑制的老年患者,尚无成熟的理想方法。本研究旨在调查在需要深度镇静的老年前列腺活检患者中,呼吸并发症与氯胺酮 - 丙泊酚与芬太尼 - 丙泊酚联合使用之间的关联。
这是一项于2020年4月至2021年3月进行的单中心、回顾性观察研究。我们纳入了计划在程序性镇静下进行前列腺活检的65岁及以上男性患者。氯胺酮 - 丙泊酚和芬太尼 - 丙泊酚由麻醉医生酌情使用。主要结局是是否需要辅助通气。次要结局是血氧饱和度(SpO)低于90%的持续时间。
我们纳入了120名65岁以上患者,92名患者纳入最终分析。麻醉医生给予氯胺酮和丙泊酚的初始剂量为1.0 mg/kg的1:1至1:4(四分位间距:0.98至1.17),或给予芬太尼初始剂量0.05至0.1 mg以及丙泊酚靶控输注2.8 μg/ml(四分位间距:2.0至3.0),随后由麻醉医生酌情给予额外剂量。与芬太尼 - 丙泊酚相比,氯胺酮 - 丙泊酚辅助通气需求减少,SpO2低于90%的持续时间更短(95.7%对4.3%,P < 0.05;0.64分钟对0.17分钟,P = 0.26)。
在对老年患者进行需要深度镇静的程序性镇静和镇痛过程中,与芬太尼 - 丙泊酚相比,氯胺酮 - 丙泊酚辅助通气需求显著减少。